Brendan T. Griffin

Biopharmaceutical challenges associated with drugs with low aqueous solubility—The potential impact of lipid-based formulations

Caitríona M. O’Driscoll, Brendan T. Griffin · Advanced Drug Delivery Reviews · 2007 · 288 citations

Lipid Preparation, Pharmaceutical Science, Lipid-based Formulations +9

The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.

Elaine F. Enright, Cormac G. M. Gahan, Susan A. Joyce et al. · PubMed · 2016 · 137 citations

Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: Case studies with fenofibrate

Brendan T. Griffin, Martin Kuentz, Maria Vertzoni et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2013 · 125 citations

Lipid Analysis, Lipid Preparation, Case Studies +10

Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel

S. Cushen, Derek G. Power, Kevin P. Murphy et al. · Clinical Nutrition ESPEN · 2016 · 95 citations

Urology, Oncology, Genitourinary Cancer +4

Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility

Elaine F. Enright, Susan A. Joyce, Cormac G. M. Gahan et al. · Molecular Pharmaceutics · 2017 · 72 citations